India’s bioeconomy hits $165.7 billion as govt unveils fresh biopharma push
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
The agreement will combine Biocytogen’s cutting-edge fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive drug development
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance
The company has achieved a turnover of around Rs 100 crore in FY 2025–26 and aims to achieve a turnover of Rs 500 crore in next three years
The center brings together hands on technology demonstrations, application expertise, and commercial operations
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
Subscribe To Our Newsletter & Stay Updated